MedPath

Metabolomic Embryo Profiles of Obese in Vitro Fertilization (IVF) Patients and Their Relationship With Polycystic Ovary Syndrome (PCO)

Completed
Conditions
Infertility
Obesity
Interventions
Other: Culture medium metabolomic analysis
Registration Number
NCT01448863
Lead Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Brief Summary

The present study aims to elucidate if there is a metabolomic profile alteration in the embryos of obese women in order to understand if the reduced implantation rate observed in these patients is directly related to this factor. Furthermore, the investigators seek to establish if there is any difference between obese women with Polycystic Ovary Syndrome (PCO) and without PCO. The investigators compare these metabolomic profile embryos with embryos of egg-donation programme.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • BMI > 30 kg/m2
  • Age < 38 years old
  • Non smokers
  • First IVF cycle (groups 2 & 3, not Control group)
  • Normal uterus (seen by ultrasound)
  • normal basal hormonal profile(FSH,LH,estradiol,testosterone,androstenedione, insulin, SHBG, glucose, AMH)
  • Antral follicle count(> 5 FA for each ovary)
  • Menses every 25-35 days.
Exclusion Criteria
  • < 5 or > 20 oocytes retrieved after stimulation cycle
  • estradiol >3000 pg/ml or progesterone > 1,5 ng/ml on the hCG day.
  • < 2 evolutive embryos in the culture medium.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
NO PCOCulture medium metabolomic analysisObese women without Polycystic Ovarian Syndrome
WITH PCOCulture medium metabolomic analysisObese women with Polycystic Ovarian Syndrome
CONTROLCulture medium metabolomic analysisFertile women (egg-donors)
Primary Outcome Measures
NameTimeMethod
Metabolic profile of culture media of Day 3 embryos3 days

Determine differences in the metabolomic profile of the culture media of day 3 embryos, obtained after in vitro fertilization, according to the presence of obesity associated or not with polycystic ovary syndrome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IVI Valencia

🇪🇸

Valencia, Spain

© Copyright 2025. All Rights Reserved by MedPath